Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

PAVmed Q3 2023 Adj EPS $(0.22) Misses $(0.14) Estimate, Sales $783.00K Beat $660.00K Estimate

Author: Benzinga Newsdesk | November 14, 2023 06:45pm
PAVmed (NASDAQ:PAVM) reported quarterly losses of $(0.22) per share which missed the analyst consensus estimate of $(0.14) by 57.14 percent. This is a 46.67 percent decrease over losses of $(0.15) per share from the same period last year. The company reported quarterly sales of $783.00 thousand which beat the analyst consensus estimate of $660.00 thousand by 18.64 percent. This is a 930.26 percent increase over sales of $76.00 thousand the same period last year.

Posted In: PAVM


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist